Survey results add to hopes of drug discovery outsourcing rise 17-Apr-2012 By Nick Taylor Positive survey results have added to evidence that outsourcing of drug discovery can partly offset weakness in GLP toxicology.
Outsourcing penetration set for double-digit growth in ‘11 Outsourcing penetration set for double-digit growth in ‘11 12-Apr-2011 By Nick Taylor Outsourcing penetration growth will hit double-digits, above analyst expectations, in 2011 and offset flat R&D budgets, found an RW Baird survey.
GSK to strip down through outsourcing and offshoring GSK to strip down through outsourcing and offshoring 26-Oct-2007 By Kirsty Barnes GlaxoSmithKline (GSK) is planning to strip itself down closer to the bare bones of the business through further outsourcing and offshoring, with hopes of making itself into a lean, mean, pharma machine.